Effect of Home-based Training Program for Kidney Transplant Recipients (HOMETRAIN-KTR)
Evaluating the Effect of a Structured Home-based Physical Training Program for Kidney Transplant Recipients With Impaired Pre-transplant Physical Function
1 other identifier
interventional
200
1 country
1
Brief Summary
Does home-based training work in kidney transplant recipients with reduced physical function? The goal of this clinical trial is to learn if home-based training works to better physical function in adult kidney transplant recipients. It will also learn about participants preoperative physical function. The main question it aim to answer is
- Does home-based training improves physical function in kidney transplant recipients.
- All the participants are assessed to have reduced physical function before the transplantation Participants will:
- follow either a home-based training program or todays standard of physical activity after kidney transplantation
- the program starts 4 weeks after the transplantation and lasts for 12 weeks. A physiotherapist will help the participants in the beginning.
- the program consists of both cardio-training, strength-straining and optional activity
- the training group will be followed up every week by phone. Their activity will be documented via patients logs and heart rate monitor.
- the effect of the training will be evaluated one year after the transplantation
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2024
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 7, 2024
CompletedFirst Submitted
Initial submission to the registry
April 15, 2024
CompletedFirst Posted
Study publicly available on registry
April 23, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2028
April 24, 2024
April 1, 2024
2.9 years
April 15, 2024
April 22, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
6-minute walking distance test
Test of physical function. How many meters the patient manage to walk in 6 minutes.
Baseline and after 52 weeks
Clinical Frailty Scale
Test for frailty. Validated test for this purpose. Score 1-9. The higher the score the more frail
Baseline and after 52 weeks
Secondary Outcomes (4)
Hand-grip strength
Baseline, week 7, week 26 and week 52
30 seconds Sit-to-stand test
Baseline, week 7, week 26 and week 52
Bone density test
Week 7 and week 52
Bioelectrical impedance phase angle to measure muscle mass and strength.
Week 7 and 52
Study Arms (2)
Home-based training
EXPERIMENTALStructured home-based training program over 12 week period (in addition to standard care). The program has been prepared by physiotherapists and starts 4 weeks after kidney transplantation. It consists of 2 sessions of strength training and 1 session of cardio training each week. In addition, optional training sessions on the other days of the week. The patients will be followed up by phone every week, heart rate monitor and patients logs. A physiotherapist will guide the patients in the beginning of the intervention period
Standard of care
NO INTERVENTIONThis group will undergo standard physical training program in addition to standard care. They will be informed about the importance of regular exercise after discharge from hospital.
Interventions
Eligibility Criteria
You may qualify if:
- Being 18 years old or older and going through Ktx
- Scores 75 or lower at physical function at SF-36 at time of KTx
- Able to perform the 6MWT
- Able to speak, read and understand Norwegian or English
- Being mentally and cognitively capable of participating in the intervention and responding to follow-up questionnaires
You may not qualify if:
- \- none
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Oslo University Hospital
Oslo, 0372, Norway
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marit Helen Andersen
Oslo University Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Both participants and investigators will know which arm the participants are randomized to. Training is not easy to mask
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Nephrologist/phd-student
Study Record Dates
First Submitted
April 15, 2024
First Posted
April 23, 2024
Study Start
February 7, 2024
Primary Completion (Estimated)
January 1, 2027
Study Completion (Estimated)
January 1, 2028
Last Updated
April 24, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share